Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization

被引:56
|
作者
Zhao, L [1 ]
O'Reilly, MK [1 ]
Shultz, MD [1 ]
Chmielewski, J [1 ]
机构
[1] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
关键词
D O I
10.1016/S0960-894X(03)00040-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Peptides derived from the interfacial region of dimeric HIV-1 integrase were evaluated as inhibitors of integrase's 3'-endonuclease activity. Three peptides were found to be moderately potent inhibitors with IC50 values in the low micromolar range. The mode of inhibition was probed through protein crosslinking experiments. Active interfacial peptides were found to inhibit crosslinking of the dimeric form of integrase. Interfacial peptides that were poor inhibitors had no effect on integrase crosslinking. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1175 / 1177
页数:3
相关论文
共 50 条
  • [31] Integrase inhibitors in the treatment of HIV-1 infection
    Powderly, William G.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (12) : 2485 - 2488
  • [32] Clinical progress of HIV-1 integrase inhibitors
    Al-Mawsawi, Laith Q.
    Al-Safi, Rasha I.
    Neamati, Nouri
    EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (02) : 213 - 225
  • [33] HIV-1 Integrase Strand Transfer Inhibitors
    Johns, Brian A.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 45, 2010, 45 : 263 - +
  • [34] Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase:: A single mode of inhibition for the three HIV enzymes?
    Camarasa, Maria-Jose
    Velazquez, Sonsoles
    San-Felix, Ana
    Perez-Perez, Maria-Jesus
    Gago, Federico
    ANTIVIRAL RESEARCH, 2006, 71 (2-3) : 260 - 267
  • [35] Peptide-based inhibitors of HIV-1 RT dimerization and polpolyprotein maturation
    Clayette, Pascal
    Agopian, Audrey
    Dereuddre-Bosquet, Nathalie
    Goffinet, Chritine
    Yousfi, Rahima
    Depollier, Jerome
    Storck, Karen
    Gros, Eric
    Keppler, Oliver
    Divita, Gilles
    ANTIVIRAL RESEARCH, 2008, 78 (02) : A27 - A27
  • [36] Restricting the flexibility of crosslinked, interfacial peptide inhibitors of HIV-1 protease
    Ulysse, LG
    Chmielewski, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (22) : 3281 - 3286
  • [37] Characterization of natural polymorphic sites of the HIV-1 integrase before the introduction of HIV-1 integrase inhibitors in Germany
    Meixenberger, Karolin
    Yousef, Kaveh Pouran
    Somogyi, Sybille
    Fiedler, Stefan
    Bartmeyer, Barbara
    von Kleist, Max
    Kuecherer, Claudia
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 157 - 157
  • [38] Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds
    Maes, M.
    Levin, A.
    Hayouka, Z.
    Shalev, E.
    Loyter, A.
    Friedler, A.
    JOURNAL OF PEPTIDE SCIENCE, 2010, 16 : 163 - 163
  • [39] Peptide inhibitors of HIV-1 integrase: From mechanistic studies to improved lead compounds
    Maes, Michal
    Levin, Aviad
    Hayouka, Zvi
    Shalev, Deborah E.
    Loyter, Abraham
    Friedler, Assaf
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (22) : 7635 - 7642
  • [40] Update on HIV integrase inhibitors for the treatment of HIV-1 infection
    Max, Blake
    FUTURE VIROLOGY, 2019, 14 (10) : 693 - 709